Drug researcher Compugen Ltd. (CGEN) said Monday it has named Avihai Shen as interim chief financial officer, replacing Dikla Czaczkes Axselbrad, who agreed to step down.<br /><br />Dr. Anat Cohen-Dayag, Compugen's President and chief executive, said "The company and Dikla agreed that Dikla would step down from her position as the Company's CFO. We thank her for her contributions and wish her every success in her future endeavors."<br /><br />Ms. Axselbrad had been CFO since 2008, according to the company's website. Last month, the company responded to newspaper reports alleging that the Israel Securities Authority was investigating Ms. Axselbrad's husband for insider trading.<br /><br />In a statement at the time, Board Chairman Martin Gerstel said that though certain officers of the company, including Ms. Axselbrad, have been investigated by the ISA, the company itself was not a subject of that investigation. He also said at the time that no changes were being made regarding Ms. Axselbrad's role at the company, though that decision would be subject to review as additional information became available.<br /><br />Before Compugen, Mr. Shen has served as CFO at Delek Energy US, Retalix US and Arotech Corp., the company said.